Sulisobenzone

Sulisobenzone

SCHEMBL489977

COc1cc(O)c(C(=O)c2ccccc2)cc1S(=O)(=O)O.[NaH]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.97
MAPT P10636 5/20 0.97
KMT2A Q03164 4/20 0.97
ALDH1A1 P00352 2/20 0.97
HPGD P15428 3/20 0.68
KDM4E B2RXH2 2/20 0.68
HSD17B10 Q99714 2/20 0.68
CYP3A4 P08684 1/20 0.68
RECQL P46063 1/20 0.68
MAPK1 P28482 2/20 0.52
HTT P42858 2/20 0.52
CYP1A2 P05177 2/20 0.52
CYP2D6 P10635 2/20 0.52
CYP2C19 P33261 2/20 0.52
PGR P06401 1/20 0.52
SLC6A2 P23975 1/20 0.52
PDE4A P27815 1/20 0.52
HRH1 P35367 1/20 0.52
SLC6A3 Q01959 1/20 0.52
PDE4D Q08499 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulisobenzone SCHEMBL29360128 0.99 LMNA (1.00) LMNAMAPTKMT2AALDH1A1HPGD
Sulisobenzone SCHEMBL16330 0.99 LMNA (1.00) LMNAMAPTKMT2AALDH1A1HPGD
Sulisobenzone SCHEMBL167868 0.99 LMNA (1.00) LMNAMAPTKMT2AALDH1A1HPGD
Sulisobenzone SCHEMBL9474717 0.99 LMNA (1.00) LMNAMAPTKMT2AALDH1A1HPGD
Sulisobenzone SCHEMBL6295950 0.97 LMNA (0.97) LMNAMAPTKMT2AALDH1A1HPGD
Sulisobenzone SCHEMBL10723301 0.97 LMNA (0.97) LMNAMAPTKMT2AALDH1A1HPGD
Sulisobenzone SCHEMBL11142507 0.97 LMNA (0.97) LMNAMAPTKMT2AALDH1A1HPGD
Sulisobenzone SCHEMBL10621764 0.97 MAPT (0.97) LMNAMAPTKMT2AALDH1A1HPGD
Sulisobenzone SCHEMBL22712408 0.97 LMNA (0.97) LMNAMAPTKMT2AALDH1A1HPGD
Sulisobenzone SCHEMBL11277589 0.97 LMNA (0.97) LMNAMAPTKMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 908 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260108436-A1 SUNSCREEN COMPOSITION WITH SPF BOOSTERS SAES GETTERS S.P.A. (IT) 2026-04-23 US claimed
US-20260108435-A1 SUNSCREEN COMPOSITION WITH FUNCTIONALIZED ZEOLITE SPF BOOSTERS SAES GETTERS S.P.A. (IT) 2026-04-23 US claimed
EP-4648735-B1 SUNSCREEN COMPOSITION WITH SPF BOOSTERS GETTERS SPA (IT) 2026-03-11 EP claimed
EP-4648734-B1 SUNSCREEN COMPOSITION WITH FUNCTIONALIZED ZEOLITE SPF BOOSTERS GETTERS SPA (IT) 2026-02-18 EP claimed
EP-4648735-A1 SUNSCREEN COMPOSITION WITH SPF BOOSTERS Saes Getters S.p.A. (IT) 2025-11-19 EP claimed
EP-4648734-A1 SUNSCREEN COMPOSITION WITH FUNCTIONALIZED ZEOLITE SPF BOOSTERS Saes Getters S.p.A. (IT) 2025-11-19 EP claimed
CN-117801714-A Photovoltaic module packaging adhesive film and preparation method and application thereof 极电光能有限公司 2024-04-02 CN claimed
CN-115304863-A Antibacterial plastic film and production process thereof 江苏益森新材料有限公司 2022-11-08 CN claimed
CN-113773569-A Antibacterial bath ball and preparation method thereof 衢州市洁妮肤日用品有限责任公司 2021-12-10 CN claimed
CN-113123011-B Elastic ribbon with massage function 江西绣丽织带有限公司 2021-11-05 CN claimed
US-20140017176-A1 FILM FOAMING HYDROALCOHOLIC FOAM STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) 2014-01-16 US claimed
WO-2012149355-A1 CLEAR WET SPRAYS AND GELS ISP INVESTMENTS INC. (US) 2012-11-01 WO claimed
US-20060233727-A9 Film foaming hydroalcoholic foam CONNETICS AUSTRALIA PTY LTD. (AU) 2006-10-19 US claimed
US-20060067894-A1 Film foaming hydroalcoholic foam CONNETICS AUSTRALIA PTY LTD. (AU) 2006-03-30 US claimed
EP-1594454-A1 FILM FORMING HYDROALCOHOLIC FOAM Connetics Australia Pty Limited (AU) 2005-11-16 EP claimed
EP-1570839-A1 COMPOSITION FOR PREPARATION FOR EXTERNAL USE ON SKIN AND METHOD OF USING THE SAME Kosé Corporation (JP) 2005-09-07 EP claimed
WO-2004071479-A1 FILM FOAMING HYDROALCOHOLIC FOAM CONNETICS AUSTRALIA PTY LTD (AU) 2004-08-26 WO claimed
US-6077520-A ANTI-AGING TOPICAL COMPOSITION INCLUDING AT LEAST ONE OF SULFONYLETHYLENEAMINE OR MERCAPTOSULFONYLETHYLENEAMINE COMPOUNDS OF GIVEN FORMULA AND SPECIFIED ULTRAVIOLET LIGHT PROTECTIVE AGENTS SHISEIDO COMPANY, LTD. (JP) 2000-06-20 US claimed
US-6046330-A Complexes of ultraviolet absorbers and quaternary ammonium compounds which are substantially free from unwanted salts MILLIKEN & COMPANY 2000-04-04 US claimed
EP-0834302-A1 Compositions comprising glutathione liposomes Boehringer Ingelheim Limited (GB) 1998-04-08 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260108435-A1 SUNSCREEN COMPOSITION WITH FUNCTIONALIZED ZEOLITE SPF BOOSTERS SOD1, MCM5, GSTM1 LMNA 819/4885MAPT 3109/4885KMT2A 1087/4885
US-20260108436-A1 SUNSCREEN COMPOSITION WITH SPF BOOSTERS BRCA1, SQOR, NDUFB5 LMNA 2402/4885MAPT 3653/4885KMT2A 3809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.